Brought to you by 
ChanRx closes its Series A venture round
07 Dec 2011
Executive Summary
ChanRx Inc. (small molecules aimed at ion channel targets for atrial fibrillation) has raised an undisclosed amount of money through its Series A venture round. Sante Ventures and Dr. Arthur Brown, the company’s founder, participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ChanRx closes its Series A venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice